Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health.

For more information, please visit https://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics

Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.